Hendricks A - Search Results

1

A novel unconventional T cell population enriched in Crohn's disease.

Rosati E, Rios Martini G, Pogorelyy MV, Minervina AA, Degenhardt F, Wendorff M, Sari S, Mayr G, Fazio A, Dowds CM, Hauser C, Tran F, von Schönfels W, Pochhammer J, Salnikova MA, Jaeckel C, Gigla JB, Sabet SS, Hübenthal M, Schiminsky E, Schreiber S, Rosenstiel PC, Scheffold A, Thomas PG, Lieb W, Bokemeyer B, Witte M, Aden K, Hendricks A, Schafmayer C, Egberts JH, Mamedov IZ, Bacher P, Franke A. Rosati E, et al. Among authors: hendricks a. Gut. 2022 Nov;71(11):2194-2204. doi: 10.1136/gutjnl-2021-325373. Epub 2022 Mar 9. Gut. 2022. PMID: 35264446 Free PMC article.

2

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer.

Hinz S, Röder C, Tepel J, Hendricks A, Schafmayer C, Becker T, Kalthoff H. Hinz S, et al. Among authors: hendricks a. BMC Cancer. 2015 Dec 16;15:953. doi: 10.1186/s12885-015-1989-z. BMC Cancer. 2015. PMID: 26674974 Free PMC article.

3

Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.

Hinz S, Hendricks A, Wittig A, Schafmayer C, Tepel J, Kalthoff H, Becker T, Röder C. Hinz S, et al. Among authors: hendricks a. BMC Cancer. 2017 Jan 13;17(1):53. doi: 10.1186/s12885-016-3035-1. BMC Cancer. 2017. PMID: 28086834 Free PMC article.

4

Long-term quality of life after endovac-therapy in anastomotic leakages after esophagectomy.

Heits N, Bernsmeier A, Reichert B, Hauser C, Hendricks A, Seifert D, Richter F, Schafmayer C, Ellrichmann M, Schniewind B, Hampe J, Becker T, Egberts JH. Heits N, et al. Among authors: hendricks a. J Thorac Dis. 2018 Jan;10(1):228-240. doi: 10.21037/jtd.2017.12.31. J Thorac Dis. 2018. PMID: 29600053 Free PMC article.

5

Identifying patients with an unfavorable prognosis in early stages of colorectal carcinoma.

Hendricks A, Eggebrecht GL, Bernsmeier A, Geisen R, Dall K, Trauzold A, Becker T, Kalthoff H, Schafmayer C, Röder C, Hinz S. Hendricks A, et al. Oncotarget. 2018 Jun 8;9(44):27423-27434. doi: 10.18632/oncotarget.25384. eCollection 2018 Jun 8. Oncotarget. 2018. PMID: 29937995 Free PMC article.

6

Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).

von Schönfels W, Beckmann JH, Ahrens M, Hendricks A, Röcken C, Szymczak S, Hampe J, Schafmayer C. von Schönfels W, et al. Among authors: hendricks a. Surg Obes Relat Dis. 2018 Oct;14(10):1607-1616. doi: 10.1016/j.soard.2018.07.012. Epub 2018 Jul 24. Surg Obes Relat Dis. 2018. PMID: 30146425

7

Genome-wide association analysis of diverticular disease points towards neuromuscular, connective tissue and epithelial pathomechanisms.

Schafmayer C, Harrison JW, Buch S, Lange C, Reichert MC, Hofer P, Cossais F, Kupcinskas J, von Schönfels W, Schniewind B, Kruis W, Tepel J, Zobel M, Rosendahl J, Jacobi T, Walther-Berends A, Schroeder M, Vogel I, Sergeev P, Boedeker H, Hinrichsen H, Volk A, Erk JU, Burmeister G, Hendricks A, Hinz S, Wolff S, Böttner M, Wood AR, Tyrrell J, Beaumont RN, Langheinrich M, Kucharzik T, Brezina S, Huber-Schönauer U, Pietsch L, Noack LS, Brosch M, Herrmann A, Thangapandi RV, Schimming HW, Zeissig S, Palm S, Focke G, Andreasson A, Schmidt PT, Weitz J, Krawczak M, Völzke H, Leeb G, Michl P, Lieb W, Grützmann R, Franke A, Lammert F, Becker T, Kupcinskas L, D'Amato M, Wedel T, Datz C, Gsur A, Weedon MN, Hampe J. Schafmayer C, et al. Among authors: hendricks a. Gut. 2019 May;68(5):854-865. doi: 10.1136/gutjnl-2018-317619. Epub 2019 Jan 19. Gut. 2019. PMID: 30661054

8

Shotgun lipidomics-based characterization of the landscape of lipid metabolism in colorectal cancer.

Wang Y, Hinz S, Uckermann O, Hönscheid P, von Schönfels W, Burmeister G, Hendricks A, Ackerman JM, Baretton GB, Hampe J, Brosch M, Schafmayer C, Shevchenko A, Zeissig S. Wang Y, et al. Among authors: hendricks a. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Mar;1865(3):158579. doi: 10.1016/j.bbalip.2019.158579. Epub 2019 Nov 30. Biochim Biophys Acta Mol Cell Biol Lipids. 2020. PMID: 31794862

9

Rapid response of stage IV colorectal cancer with APC/TP53/KRAS mutations to FOLFIRI and Bevacizumab combination chemotherapy: a case report of use of liquid biopsy.

Hendricks A, Rosenstiel P, Hinz S, Burmeister G, Röcken C, Boersch K, Schafmayer C, Becker T, Franke A, Forster M. Hendricks A, et al. BMC Med Genet. 2020 Jan 3;21(1):3. doi: 10.1186/s12881-019-0941-5. BMC Med Genet. 2020. PMID: 31900123 Free PMC article.

10

Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies.

Hendricks A, Amallraja A, Meißner T, Forster P, Rosenstiel P, Burmeister G, Schafmayer C, Franke A, Hinz S, Forster M, Williams CB. Hendricks A, et al. Cancers (Basel). 2020 Feb 8;12(2):393. doi: 10.3390/cancers12020393. Cancers (Basel). 2020. PMID: 32046290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

416 results

Search Page